Orion Corporation is holding a Capital Markets Day for investors and financial analysts on Tuesday, 22 November 2005, at 08.30 - 12.00, at the Grocers' Hall, address Princes Street, London EC2R 8AD.
An invitation to the event, including the programme, is attached for your information.
The key topics to be dealt with include the results of the two major Phase 3 studies, Revive II and Survive conducted with the heart failure drug levosimendan (Simdax), as well as a review of the R&D pipeline of Orion Pharma. Also, the plan to demerge Orion into two new companies will be presented and discussed.
The presentations will start at 9.00. Coffee is served before the seminar. A buffet lunch will be served after the presentations. For registration to the event, kindly follow the advise given in the invitation.
The event will be webcasted on line. An on-demand re-play will become available on our homepage as of 23 November.
Looking forward to seeing you in London
Anne Allo
VP, Investor Relations
Orion Corporation
+358 10 429 3735
